Epigallocatechin gallate (EGCG) attenuates myocardial hypertrophy and fibrosis induced by transverse aortic constriction via inhibiting the Akt/mTOR pathway

References

• Aoyagi T, Matsui T. 2011. Phosphoinositide-3 kinase signaling in cardiac hypertrophy and heart failure. Curr Pharm Des. 17(18):1818–1824.
   PubMed Web of Science ®Google Scholar
• Caban M, Owczarek K, Chojnacka K, Lewandowska U. 2019. Overview of polyphenols and polyphenol-rich extracts as modulators of IGF-1, IGF-1R, and IGFBP expression in cancer diseases. J Fun Foods. 52:389–407.
   Web of Science ®Google Scholar
• Cai Y, Yu S-S, Chen T-T, Gao S, Geng B, Yu Y, Ye J-T, Liu P-Q. 2013. EGCG inhibits CTGF expression via blocking NF-κB activation in cardiac fibroblast. Phytomedicine. 20(2):106–113.
   PubMed Web of Science ®Google Scholar
• Chen YL, Abraham DJ, Xu SW, Pearson JD, Black CM, Lyons KM, Leask A. 2004. CCN2 (connective tissue growth factor) promotes fibroblast adhesion to fibronectin. Mol Biol Cell. 15(12):5635–5646.
   PubMed Web of Science ®Google Scholar
• Chen X, Dong XS, Gao HY, Jiang YF, Jin YL, Chang YY, Chen LY, Wang JH. 2016. Suppression of HSP27 increases the anti-tumor effects of quercetin in human leukemia U937 cells . Mol Med Rep. 13(1):689–696.
   PubMed Web of Science ®Google Scholar
• Chen J, Wu J, Li L, Zou YZ, Zhu DL, Gao PJ. 2011. Effect of an acute mechanical stimulus on aortic structure in the transverse aortic constriction mouse model. Clin Exp Pharmacol Physiol. 38(9):570–576.
   PubMed Web of Science ®Google Scholar
• Condorelli G, Morisco C, Latronico MV, Claudio PP, Dent P, Tsichlis P, Condorelli G, Frati G, Drusco A, Croce CM, et al. 2002. TNF-alpha signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alpha receptor. Faseb J. 16(13):1732–1737.
   PubMed Web of Science ®Google Scholar
• Deka A, Vita JA. 2011. Tea and cardiovascular disease. Pharmacol Res. 64(2):136–145.
   PubMed Web of Science ®Google Scholar
• Ellmers LJ, Scott NJ, Piuhola J, Maeda N, Smithies O, Frampton CM, Richards AM, Cameron VA. 2007. Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis. J Mol Endocrinol. 38(2):245–257.
   PubMed Web of Science ®Google Scholar
• Falcão-Pires I, Hamdani N, Borbély A, Gavina C, Schalkwijk CG, van der Velden J, van Heerebeek L, Stienen GJM, Niessen HWM, Leite-Moreira AF, et al. 2011. Diabetes mellitus worsens diastolic left ventricular dysfunction in aortic stenosis through altered myocardial structure and cardiomyocyte stiffness. Circulation. 124(10):1151–1159.
   PubMed Web of Science ®Google Scholar
• Frey N, Katus HA, Olson EN, Hill JA. 2004. Hypertrophy of the heart: a new therapeutic target? Circulation. 109(13):1580–1589.
   PubMed Web of Science ®Google Scholar
• Frey N, Olson E. 2003. Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol. 65(1):45–79.
   PubMedGoogle Scholar
• Heinzel FR, Hohendanner F, Jin G, Sedej S, Edelmann F. 2015. Myocardial hypertrophy and its role in heart failure with preserved ejection fraction. J Appl Physiol (1985)). 119(10):1233–1242.
   PubMed Web of Science ®Google Scholar
• Higdon JV, Frei B. 2003. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr. 43(1):89–143.
   PubMed Web of Science ®Google Scholar
• Ikeda M, Ide T, Fujino T, Matsuo Y, Arai S, Saku K, Kakino T, Oga Y, Nishizaki A, Sunagawa K. 2015. The Akt-mTOR axis is a pivotal regulator of eccentric hypertrophy during volume overload. Sci Rep. 5:15181–15881.
   PubMed Web of Science ®Google Scholar
• Lee H, Yoo YS, Lee D, Song EJ. 2013. Cholesterol induces cardiac hypertrophy by activating the AKT pathway. J Steroid Biochem Mol Biol. 138:307–313.
   PubMed Web of Science ®Google Scholar
• Li HL, Huang Y, Zhang CN, Liu G, Wei YS, Wang AB, Liu YQ, Hui RT, Wei CM, Williams GM, et al. 2006. Epigallocathechin-3 gallate inhibits cardiac hypertrophy through blocking reactive oxidative species-dependent and -independent signal pathways. Free Radic Biol Med. 40(10):1756–1775.
   PubMed Web of Science ®Google Scholar
• Li C, Li X, Gao X, Zhang R, Zhang Y, Liang H, Xu C, Du W, Zhang Y, Liu X, et al. 2014. MicroRNA-328 as a regulator of cardiac hypertrophy. Int J Cardiol. 173(2):268–276.
   PubMed Web of Science ®Google Scholar
• Lipson Kenneth E, Carol W, Yuchin T, Spong S. 2012. CTGF is a central mediator of tissue remodeling and fibrosis and its inhibition can reverse the process of fibrosis. Fibrogenesis Tissue Repair. 5(S1):24–43.
   Google Scholar
• Liu B, Yan W. 2019. Lipophilization of EGCG and effects on antioxidant activities. Food Chem. 272:663–669.
   PubMed Web of Science ®Google Scholar
• Liu Z-W, Zhu H-T, Chen K-L, Dong X, Wei J, Qiu C, Xue J-H. 2013. Protein kinase RNA-like endoplasmic reticulum kinase (PERK) signaling pathway plays a major role in reactive oxygen species (ROS)-mediated endoplasmic reticulum stress-induced apoptosis in diabetic cardiomyopathy. Cardiovasc Diabetol. 12:158–166.
   PubMed Web of Science ®Google Scholar
• Molkentin JD, Dorn II GW. 2001. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol. 63(1):391–426.
   PubMedGoogle Scholar
• Negri A, Naponelli V, Rizzi F, Bettuzzi S. 2018. Molecular targets of epigallocatechin-gallate (EGCG): a special focus on signal transduction and cancer. Nutrients. 10:1936–1952.
   PubMed Web of Science ®Google Scholar
• Sergeeva IA, Christoffels VM. 2013. Regulation of expression of atrial and brain natriuretic peptide, biomarkers for heart development and disease. Biochim Biophys Acta - Molecular Basis of Disease. 1832(12):2403–2413.
   PubMed Web of Science ®Google Scholar
• Sheng R, Gu Z-L, Xie M-L. 2013. Epigallocatechin gallate, the major component of polyphenols in green tea, inhibits telomere attrition mediated cardiomyocyte apoptosis in cardiac hypertrophy. Int J Cardiol. 162(3):199–209.
   PubMed Web of Science ®Google Scholar
• Sheng R, Gu Z-l, Xie M-l, Zhou W-X, Guo C-Y. 2009. EGCG inhibits proliferation of cardiac fibroblasts in rats with cardiac hypertrophy. Planta Med. 75(2):113–120.
   PubMed Web of Science ®Google Scholar
• Sheng R, Gu Z, Xie M, Zhou W, Guo C. 2006. EGCG inhibition against collagen accumulation and cell proliferation in cardiac hypertrophy. Chinese Pharmacol Bull. 22:1095–2009.
   Google Scholar
• Sheng R, Gu Z, Xie M, Zhou W, Guo C. 2007. EGCG inhibits cardiomyocyte apoptosis in pressure overload-induced cardiac hypertrophy and protects cardiomyocytes from oxidative stress in rats 1. Acta Pharmacol Sin. 28(2):191–201.
   PubMed Web of Science ®Google Scholar
• Shioi T, McMullen JR, Kang PM, Douglas PS, Obata T, Franke TF, Cantley LC, Izumo S. 2002. Akt/protein kinase B promotes organ growth in transgenic mice. Mol Cell Biol. 22(8):2799–2809.
   PubMed Web of Science ®Google Scholar
• Shiojima I, Walsh K. 2006. Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 20(24):3347–3365.
   PubMed Web of Science ®Google Scholar
• Sugden PH. 1999. Signaling in myocardial hypertrophy: life after calcineurin? Circ Res. 84(6):633–646.
   PubMed Web of Science ®Google Scholar
• Tagashira H, Bhuiyan S, Shioda N, Hasegawa H, Kanai H, Fukunaga K. 2010. Sigma1-receptor stimulation with fluvoxamine ameliorates transverse aortic constriction-induced myocardial hypertrophy and dysfunction in mice. Am J Physiol Heart Circ Physiol. 299(5):H1535–H1545.
   PubMed Web of Science ®Google Scholar
• Van Aller GS, Carson JD, Tang W, Peng H, Zhao L, Copeland RA, Tummino PJ, Luo L. 2011. Epigallocatechin gallate (EGCG), a major component of green tea, is a dual phosphoinositide-3-kinase/mTOR inhibitor. Biochem Biophys Res Commun. 406(2):194–199.
   PubMed Web of Science ®Google Scholar
• Wang J, Man GCW, Chan TH, Kwong J, Wang CC. 2018. A prodrug of green tea polyphenol (-)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer. Cancer Lett. 412:10–20.
   PubMed Web of Science ®Google Scholar
• Weber KT, Sun Y, Tyagi SC, Cleutjens JP. 1994. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol. 26(3):279–292.
   PubMed Web of Science ®Google Scholar
• Yan H-J, Qi G-Q, Ma Y. 2019. Effect of propofol on myocardial ischemia-reperfusion injury through MAPK/ERK pathway. Eur Rev Med Pharmacol Sci. 23:11051–11061.
   PubMed Web of Science ®Google Scholar
• Yang E, Lee J, Lee S, Kim E, Moon Y, Jung Y, Park S, Cho M. 2014. EGCG attenuates autoimmune arthritis by inhibition of STAT3 and HIF-1α with Th17/Treg control. PloS One. 9(2):86–102.
   Web of Science ®Google Scholar